Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             139 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Antidepressants alleviate the impact of reinforcer downshift Nikiforuk, Agnieszka
 2009
 19 Supplement 1 p. 41-48
8 p.
 artikel
2 Author Index 2009
 19 Supplement 1 p. S169-S170
2 p.
 artikel
3 Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents Fattore, Liana
 2009
 19 Supplement 1 p. 487-498
12 p.
 artikel
4 Blood, adipose tissue and brain levels of the cannabinoid ligands WIN-55,212 and SR-141716A after their intraperitoneal injection in mice: Compound-specific and area-specific distribution within the brain Barna, I.
 2009
 19 Supplement 1 p. 533-541
9 p.
 artikel
5 C.06.03 Choosing between antipsychotics – can patient outcomes be improved with new agents? Schreiner, A.
 2009
 19 Supplement 1 p. S710-S711
2 p.
 artikel
6 C.13.04 Clinical implications of increasing SWS in insomnia Walsh, J.K.
 2009
 19 Supplement 1 p. S717-
1 p.
 artikel
7 C.13.01 Electrophysiological characteristics and regulation of SWS Dijk, D.J.
 2009
 19 Supplement 1 p. S716-
1 p.
 artikel
8 C.01.03 Melatonin agonism in the treatment of sleep-wake disturbances Leissner, L.
 2009
 19 Supplement 1 p. S705-S706
2 p.
 artikel
9 Conditioned place preference induced by social play behavior: Parametrics, extinction, reinstatement and disruption by methylphenidate Trezza, Viviana
 2009
 19 Supplement 1 p. 659-669
11 p.
 artikel
10 Contents 2009
 19 Supplement 1 p. IBC-
1 p.
 artikel
11 ECNP Calendar of Meetings 2009
 19 Supplement 1 p. I-
1 p.
 artikel
12 Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: A possible role of α1-adrenoceptors Tanibuchi, Yuko
 2009
 19 Supplement 1 p. 861-867
7 p.
 artikel
13 E.05.02 Novel insights into the genetics of schizophrenia based on genome-wide association studies O'Donovan, M.
 2009
 19 Supplement 1 p. S222-S223
2 p.
 artikel
14 Frontal EEG predictors of treatment outcome in major depressive disorder Iosifescu, Dan V.
 2009
 19 Supplement 1 p. 772-777
6 p.
 artikel
15 Immediate versus gradual suspension of previous treatments during switch to aripiprazole: Results of a randomized, open label study Pae, Chi-Un
 2009
 19 Supplement 1 p. 562-570
9 p.
 artikel
16 Interactions between the glycine transporter 1(GlyT1) inhibitor SSR504734 and psychoactive drugs in mouse motor behaviour Singer, Philipp
 2009
 19 Supplement 1 p. 571-580
10 p.
 artikel
17 Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: Lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice Mechanic, Jordan A.
 2009
 19 Supplement 1 p. 466-475
10 p.
 artikel
18 Keyword Index 2009
 19 Supplement 1 p. S101-S102
2 p.
 artikel
19 MDMA reinstates cocaine-seeking behaviour in mice Trigo, José Manuel
 2009
 19 Supplement 1 p. 391-397
7 p.
 artikel
20 Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray Terzian, Ana Luisa B.
 2009
 19 Supplement 1 p. 188-195
8 p.
 artikel
21 P.7.a.002 A long-term safety study of prolonged-release methylphenidate in adults with ADHD Schaeuble, B.
 2009
 19 Supplement 1 p. S679-
1 p.
 artikel
22 P.1.31 Abelson helper integration site 1 and chromosome 6 open reading frame 217 genes in schizophrenia and bipolar disorder Slonimsky, A.
 2009
 19 Supplement 1 p. S27-S28
2 p.
 artikel
23 P.4.a.019 Carbon dioxide-induced respiratory symptoms and experimental panic in healthy volunteers Colasanti, A.
 2009
 19 Supplement 1 p. S596-
1 p.
 artikel
24 P.8.a.003 Clinical and cost-effectiveness analysis of using atorvastatin for secondary stroke prevention: a Spanish perspective Mar, J.
 2009
 19 Supplement 1 p. S695-
1 p.
 artikel
25 P.2.a.022 Comorbidity between depression, anxiety disorders and infertility: effect on quality of life in Egyptian women Radwan, D.N.
 2009
 19 Supplement 1 p. S373-
1 p.
 artikel
26 P.2.12 Activation of alpha 7 nicotinic receptors improves phencyclidine-induced deficits in reversal learning McLean, S.L.
 2009
 19 Supplement 1 p. S43-S44
2 p.
 artikel
27 P.6.a.013 Decision making, impulsivity and personality traits in alcohol dependent subjects Struglia, F.
 2009
 19 Supplement 1 p. S642-S643
2 p.
 artikel
28 P.2.a.019 Decreased fronto-limbic gray matter volume associated with recurrent major depressive disorder Arnone, D.
 2009
 19 Supplement 1 p. S371-
1 p.
 artikel
29 P.2.a.036 Depression and anxiety among couples presenting for In-Vitro-Fertilization and Embryo Transfer (IVF/ET) Sonawalla, S.
 2009
 19 Supplement 1 p. S381-
1 p.
 artikel
30 P.3.a.039 Developing guidelines for the treatment of stable schizophrenia across primary and secondary care Agius, M.
 2009
 19 Supplement 1 p. S502-S503
2 p.
 artikel
31 P.3.a.008 Effects of cognitive remediation in schizophrenia patients Rodriguez, M.
 2009
 19 Supplement 1 p. S484-S485
2 p.
 artikel
32 P.3.a.022 Executive function in deficit schizophrenia Polgar, P.
 2009
 19 Supplement 1 p. S492-S493
2 p.
 artikel
33 P.1.a.006 Genetic interaction of the serotonin transporter and the cannabinoid receptor 1 affects the anxious phenotype Lazary, J.
 2009
 19 Supplement 1 p. S228-
1 p.
 artikel
34 P.3.a.025 Influence of knowledge of the Spanish consensus on physical health in schizophrenic patients in clinical practice Bobes, J.
 2009
 19 Supplement 1 p. S494-S495
2 p.
 artikel
35 P.3.a.013 Insight and clinical outcome in first episode psychosis: 1-year follow-up study Morelli, C.
 2009
 19 Supplement 1 p. S487-S488
2 p.
 artikel
36 P.1.a.012 Interaction effects between serotonin-related gene polymorphisms on emotional intelligence Kang, J.I.
 2009
 19 Supplement 1 p. S231-S232
2 p.
 artikel
37 P.4.07 Alcohol dependence and the endocannabinoid receptor 1 gene Le Strat, Y.
 2009
 19 Supplement 1 p. S85-
1 p.
 artikel
38 P.1.01 An association of the glial cell line-derived neurotrophic factor family receptor alpha-1 gene with schizophrenia Alkelai, A.
 2009
 19 Supplement 1 p. S3-S4
2 p.
 artikel
39 P.4.a.005 Outcome predictors in patients with obsessive compulsive disorder: a prospective naturalistic study Dell'Osso, B.
 2009
 19 Supplement 1 p. S588-
1 p.
 artikel
40 P.2.a.050 Post traumatic brain injury major depression and primary major depression: psychopathological and neuropsychological profiles Mauri, M.C.
 2009
 19 Supplement 1 p. S389-
1 p.
 artikel
41 P.4.a.002 Prevalence of PTSD in a sample of victims of Gwangju democratic uprising Kim, S.h.
 2009
 19 Supplement 1 p. S586-
1 p.
 artikel
42 P.1.a.015 Relationship of MAO-A and catechol-O-methyltransferase gene polymorphisms to plasma monoamine metabolites levels in patients and controls Zumarraga, M.
 2009
 19 Supplement 1 p. S233-S234
2 p.
 artikel
43 P.2.a.008 Right-sided, 1-Hz repetitive TMS compared with venlafaxine extended-release in the treatment of resistant depression: a double-blind study Bares, M.
 2009
 19 Supplement 1 p. S365-
1 p.
 artikel
44 P.2.a.005 Serum BDNF levels correlate with hippocampal volumes in first episode, medication-free depressed patients Eker, M.
 2009
 19 Supplement 1 p. S363-
1 p.
 artikel
45 P.1.a.007 The role of insulin receptor substrate-1 Gly972Arg polymorphism in the pathogenesis of Alzheimer's disease Juhasz, A.
 2009
 19 Supplement 1 p. S228-S229
2 p.
 artikel
46 P.8.b.003 Affective symptoms, body mass index and metabolic syndrome: a life course approach Gaysina, D.
 2009
 19 Supplement 1 p. S703-
1 p.
 artikel
47 P.7.b.006 Chronic methylphenidate or atomoxetine treatment alters BDNF expression in the brain of spontaneously hypertensive rats Cattaneo, A.
 2009
 19 Supplement 1 p. S686-S687
2 p.
 artikel
48 P.7.b.003 Comparison of adolescent SHR, WKY and Wistar rats in different behavioural models Langen, B.
 2009
 19 Supplement 1 p. S685-
1 p.
 artikel
49 P.1.b.007 Developmental expression and activity of carboxylesterase 1 and carboxylesterase 2 in mouse and human Zhu, H.J.
 2009
 19 Supplement 1 p. S244-S245
2 p.
 artikel
50 P.5.b.001 Expression of certain apoptotic regulators in a pharmacological experimental model of Alzheimer's disease Hasanagic, S.
 2009
 19 Supplement 1 p. S625-
1 p.
 artikel
51 P.1.b.003 Is diurnal variation in plasma brain-derived neurotrophic factor level sex-related? Choi, S.
 2009
 19 Supplement 1 p. S242-
1 p.
 artikel
52 P.2.b.01l A new preclinical model of vulnerability to depression-like behaviours Blugeot, A.
 2009
 19 Supplement 1 p. S397-
1 p.
 artikel
53 P.2.b.008 Metabotropic glutamate receptor 5: role in depression? Deschwanden, A.
 2009
 19 Supplement 1 p. S395-S396
2 p.
 artikel
54 P.1.b.017 Projection of subtypes of aggression to event related brain potentials in healthy adults with a tendency to aggression Yildirim, E.A.
 2009
 19 Supplement 1 p. S250-
1 p.
 artikel
55 P.3.b.010 Structural brain abnormalities and altered sensitivity to psychotomimetic drugs in neuregulin-1 knockout mice O'Tuathaigh, C.
 2009
 19 Supplement 1 p. S508-S509
2 p.
 artikel
56 P.3.c.059 Association between antipsychotic treatment and clinical and economic outcomes in schizophrenia and bipolar disorder Mychaskiw, M.
 2009
 19 Supplement 1 p. S544-
1 p.
 artikel
57 P.2.c.004 Basic fibroblast growth factor (FGF2) gene polymorphisms could contribute to SSRIs treatment response and tolerability Kato, M.
 2009
 19 Supplement 1 p. S405-S406
2 p.
 artikel
58 P.1.c.002 Cannabidiol lowers body weight gains in rats Ignatowska-Jankowska, B.
 2009
 19 Supplement 1 p. S252-
1 p.
 artikel
59 P.4.C.001 Drug prescriptions for treating insomnia in hospitalized patients Amboage-Paz, M.T.
 2009
 19 Supplement 1 p. S604-
1 p.
 artikel
60 P.2.c.038 Duloxetine versus placebo in patients with major depressive disorder (MDD): assessment of energy and vitality in MDD Myers-Oakes, T.M.
 2009
 19 Supplement 1 p. S425-S426
2 p.
 artikel
61 P.1.c.060 Effect of agmatine on pentilentetrazole-induced kindling in rats Aricioglu, F.
 2009
 19 Supplement 1 p. S285-S286
2 p.
 artikel
62 P.1.c.033 Effects of carnosine on long-term plasticity of perforant pathway/dentate gyrus synapses in rats: an in vivo model Dolu, N.
 2009
 19 Supplement 1 p. S270-S271
2 p.
 artikel
63 P.3.c.014 Effects of long-acting injectable risperidone on cognitive function in patients with schizophrenia Kim, S.W.
 2009
 19 Supplement 1 p. S518-
1 p.
 artikel
64 P.2.c.021 Efficacy and safety of combined therapy with moclobemide and valproic acid or carbamazepine in depressive patients Todorovic, M.
 2009
 19 Supplement 1 p. S415-S416
2 p.
 artikel
65 P.2.c.035 Fitness to drive under selective antidepressants Laux, G.
 2009
 19 Supplement 1 p. S424-
1 p.
 artikel
66 P.3.08 Clinical characteristics and treatment outcome in a representative sample of depressed inpatients Hennings, J.
 2009
 19 Supplement 1 p. S68-S69
2 p.
 artikel
67 P.6.c.003 Negative affect in depressed versus non-depressed smokers after brief nicotine abstinence Kilzieh, N.
 2009
 19 Supplement 1 p. S651-
1 p.
 artikel
68 P.1.c.016 Neuropharmacological activity of new l-valine peptidomimetics – in vitro and in vivo studies Encheva, E.
 2009
 19 Supplement 1 p. S260-S261
2 p.
 artikel
69 P.3.06 Composite tardive dystonia associated with antipsychotic drugs for treatment of bipolar affective disorder: a case study Adomaitiene, V.
 2009
 19 Supplement 1 p. S154-S155
2 p.
 artikel
70 P.4.c.004 Paroxetine in the treatment of panic disorder: a comparison between slow and standard up-titrations Buoli, M.
 2009
 19 Supplement 1 p. S606-
1 p.
 artikel
71 P.6.c.006 Personality disorders in a dual diagnosis unit Martínez-Sanvisens, D.
 2009
 19 Supplement 1 p. S652-S653
2 p.
 artikel
72 P.3.c.028 Schizophrenic patients treated with quetiapine perform better than haloperidol on theory of mind tasks Jia, H.
 2009
 19 Supplement 1 p. S526-S527
2 p.
 artikel
73 P.3.c.011 Short term treatment responsiveness of cognitive impairments in first episode of schizophrenia Miclutia, I.
 2009
 19 Supplement 1 p. S516-S517
2 p.
 artikel
74 P.3.c.042 The comparison of therapeutic efficacy, metabolism of glucose and lipid and change in prolactin in antipsychotics Kim, J.G.
 2009
 19 Supplement 1 p. S534-
1 p.
 artikel
75 P.3.c.045 Treatment efficacy and concomitant benzodiazepine use with aripiprazole versus olanzapine in acute bipolar mania Singh, M.
 2009
 19 Supplement 1 p. S536-
1 p.
 artikel
76 P.2.d.022 CYP2D6 P34S polymorphisms and mirtazapine responses in Koreans with major depression Lee, M.S.
 2009
 19 Supplement 1 p. S442-
1 p.
 artikel
77 P6.d.007 Differential effects of acute and repeated amphetamine on two animal models of human novelty-seeking behaviour Fukushiro, D.F.
 2009
 19 Supplement 1 p. S661-
1 p.
 artikel
78 P.2.d.033 Effect of desipramine and imipramine chronic administration on lipopolysaccharide-induced interleukin-1β levels in rat brain and plasma Obuchowicz, E.
 2009
 19 Supplement 1 p. S448-
1 p.
 artikel
79 P.3.d.015 Enhanced cortical dopaminergic and glutamatergic transmission and antipsychotic-like effect of risperidone by idazoxan Marcus, M.M.
 2009
 19 Supplement 1 p. S562-S563
2 p.
 artikel
80 P.3.d.001 In-vitro pharmacology of aripiprazole, its metabolite and experimental dopamine partial agonists at human dopamine D2 and D3 receptors Tadori, Y.
 2009
 19 Supplement 1 p. S554-
1 p.
 artikel
81 P.5.d.00l Effects of (R)-and (S)-1-methyl-1,2,3,4-tetrahydroisoquinoline on rotenone-induced disturbances of dopaminergic system in the rat brain Wasik, A.
 2009
 19 Supplement 1 p. S629-
1 p.
 artikel
82 P.2.d.025 Paroxetine treatment in women with menopausal depression Filovska, V.F.
 2009
 19 Supplement 1 p. S443-S444
2 p.
 artikel
83 P.2.d.008 Platelet markers before and after trazodone in depressed patients Marazziti, D.
 2009
 19 Supplement 1 p. S434-
1 p.
 artikel
84 P.1.d.012 Role of the endocannabinoid system and vanilloid TRPV1 channels in the phenotype of dopamine D3 receptor knock-out mice Micale, V.
 2009
 19 Supplement 1 p. S294-
1 p.
 artikel
85 P.2.01 Duloxetine in the treatment of bulimia nervosa: a case report Capasso, A.
 2009
 19 Supplement 1 p. S143-S144
2 p.
 artikel
86 P.4.e.004 Agoraphobia treatment: antidepressant monotherapy and combined treatments Pitti, C.T.
 2009
 19 Supplement 1 p. S614-S615
2 p.
 artikel
87 P.2.e.002 Asenapine effects on individual items on the young mania rating scale in patients with bipolar I disorder Zhao, J.
 2009
 19 Supplement 1 p. S449-
1 p.
 artikel
88 P.1.e.004 Chronic stress and antidepressant treatment have opposite effects on P-glycoprotein at the blood-brain barrier de Klerk, O.
 2009
 19 Supplement 1 p. S302-
1 p.
 artikel
89 P.2.e.030 Creatine kinase level may not be associated with motor activity but with simple mood state in Korean unmedicated bipolar patients Chung, S.
 2009
 19 Supplement 1 p. S465-S466
2 p.
 artikel
90 P.3.e.002 Do patients follow advice from physical healthcare clinics in secondary care: an audit Hodgson, R.E.
 2009
 19 Supplement 1 p. S568-
1 p.
 artikel
91 P.1.e.031 Effect of EMDR treatment in PTSD patients: clinical and biological outcomes are stable in 1-year follow-up Tavanti, M.
 2009
 19 Supplement 1 p. S318-
1 p.
 artikel
92 P.3.e.005 Factors influencing burden on the primary caregivers of remitted schizophrenic outpatients Kim, C.K.
 2009
 19 Supplement 1 p. S570-
1 p.
 artikel
93 P.2.26 Effect of MK-801 on sustained attention in rats Sukhanov, I.
 2009
 19 Supplement 1 p. S55-
1 p.
 artikel
94 P.4.01 Effects of group II metabotropic glutamate receptor antagonist, MGS0039 in rodent tests of anxiety-like behaviour Stachowicz, K.
 2009
 19 Supplement 1 p. S156-S157
2 p.
 artikel
95 P.1.e.007 Fronto-cerebellar brain dysfunction in adults with childhood ADHD during sustained attention and reward Cubillo, A.
 2009
 19 Supplement 1 p. S303-S304
2 p.
 artikel
96 P.5.e.004 Global surveillance program monitoring raters' administration and scoring of the Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog McNamara, C.
 2009
 19 Supplement 1 p. S633-
1 p.
 artikel
97 P.6.e.004 Hostility and impulsivity of nicotine dependence Min, S.
 2009
 19 Supplement 1 p. S671-
1 p.
 artikel
98 P.1.e.02l The effects of cognitive-behavioural therapy on brain regional cerebral blood flow in obsessive compulsive disorder Berk, G.
 2009
 19 Supplement 1 p. S312-
1 p.
 artikel
99 P.2.e.033 Predictors of the development of cardiometabolic abnormalities in youth with bipolar disorder on ziprasidone or placebo Correll, C.
 2009
 19 Supplement 1 p. S467-
1 p.
 artikel
100 P.3.11 Erythropoietin modulates emotional processing in biomarker models of antidepressant drug action in depressed patients Miskowiak, K.W.
 2009
 19 Supplement 1 p. S71-
1 p.
 artikel
101 P.2.e.016 Sensitivity of a comprehensive rating scale for bipolar disorders to assess improvements with treatment Bowden, C.
 2009
 19 Supplement 1 p. S457-S458
2 p.
 artikel
102 P.1.e.009 The disrupted-in-schizophrenia-1 ser704cys polymorphism and brain morphology in schizophrenia Suzuki, M.
 2009
 19 Supplement 1 p. S305-
1 p.
 artikel
103 P.3.e.019 The impact of once-daily quetiapine fumarate on length of hospitalisation in patients with mental illness Järbrink, K.
 2009
 19 Supplement 1 p. S578-
1 p.
 artikel
104 P.5.f.002 Involvement of tetrahydrobiopterin in delirium after cardiac surgery Fekkes, D.
 2009
 19 Supplement 1 p. S635-
1 p.
 artikel
105 P.1.f.002 Plasma BDNF levels of patients with somatisation disorder and their alterations after pharmacotherapy Yang, J.C.
 2009
 19 Supplement 1 p. S320-
1 p.
 artikel
106 P.2.g.007 Interactions between cholesterol and serotonin transporter polymorphism on late-life depression Bae, K.Y.
 2009
 19 Supplement 1 p. S475-
1 p.
 artikel
107 P.1.g.018 Tenses can have different effects on declarative processes Koçak, O.M.
 2009
 19 Supplement 1 p. S330-
1 p.
 artikel
108 P.1.g.003 Theory of mind deficits in unaffected relatives of patients with schizophrenia and bipolar disorder Yucel, M.O.
 2009
 19 Supplement 1 p. S322-
1 p.
 artikel
109 P.1.i.017 Amelioration of affective disorders and quality of life in obstructive sleep apnea (OSA) patients following continuous positive airway pressure (CPAP) therapy Paparrigopoulos, T.J.
 2009
 19 Supplement 1 p. S345-S346
2 p.
 artikel
110 P.1.i.034 Efficacy outcomes during longterm prolonged-release methylphenidate treatment of adults with ADHD Imhof, L.
 2009
 19 Supplement 1 p. S353-S354
2 p.
 artikel
111 P.1.i.032 Improved trophic efficacy of glial cell-derived neurotropic factor (GDNF) after combination with TGF-beta 1 both in vitro and in vivo models of parkinsonism Fernandez-Espejo, E.
 2009
 19 Supplement 1 p. S353-
1 p.
 artikel
112 P.1.i.037 Rater training on SANS and monitoring of rater performance during clinical trials Richa, G.
 2009
 19 Supplement 1 p. S355-S356
2 p.
 artikel
113 P.l.c.043 ACR325: a dopaminergic stabiliser that displays state-dependent effects in-vivo Pontón, H.
 2009
 19 Supplement 1 p. S276-
1 p.
 artikel
114 P.l.c.057 Effects of trazodone on sleep, respiratory and nocturnal movement variables in insomniac somatoform pain patients Prause, W.
 2009
 19 Supplement 1 p. S284-
1 p.
 artikel
115 P.l.c.038 Modulation of dopaminergic activity in the mesolimbic system by trace amine-associated receptor 1 (TAAR1) modification Revel, E.G.
 2009
 19 Supplement 1 p. S273-
1 p.
 artikel
116 P.1.30 Modulation by spermine of GABAA receptor endogenous phosphorylation and function Sid Ahmed, M.
 2009
 19 Supplement 1 p. S26-S27
2 p.
 artikel
117 P.4.05 Synaptic and cellular correlates of cocaine addiction in rats Kasanetz, F.
 2009
 19 Supplement 1 p. S84-
1 p.
 artikel
118 P.4.15 The COMT Val158Met genotype and prefrontal dopamine sensitivity in alcohol dependent patients and healthy controls Schellekens, A.
 2009
 19 Supplement 1 p. S91-S92
2 p.
 artikel
119 P.2.09 The source of resting and physiologically-evoked L-glutamate levels in prefrontal cortex in awake rats Hascup, E.R.
 2009
 19 Supplement 1 p. S40-S41
2 p.
 artikel
120 P.1.13 Time-dependent alterations in genes expression in rat brain after administration of antidepressants — a gene miccroarray, RT-PCR study Gaska, M.
 2009
 19 Supplement 1 p. S13-
1 p.
 artikel
121 R1.h,010 Quality of life in young and professionally active men undergoing on-pump coronary artery bypass grafting Krzych, L.J.
 2009
 19 Supplement 1 p. S336-
1 p.
 artikel
122 S.1.02 Antidepressant pharmacotherapy – 2009 and beyond Nutt, D.
 2009
 19 Supplement 1 p. S108-S109
2 p.
 artikel
123 S.1.01 Brain opioid receptor systems: molecular and functional aspects Kieffer, B.
 2009
 19 Supplement 1 p. S1-S2
2 p.
 artikel
124 S.07.05 Cannabis co-administration potentiates MDMA effects on temperature and heart rate Dumont, G.
 2009
 19 Supplement 1 p. S188-
1 p.
 artikel
125 S.02.05 Deep brain stimulation for treatment resistant depression – predictors of response Schlaepfer, T.E.
 2009
 19 Supplement 1 p. S178-
1 p.
 artikel
126 S.1.05 Depression and general medical condition Bunevicius, R.
 2009
 19 Supplement 1 p. S111-
1 p.
 artikel
127 S.16.04 DISC1 mouse model of gene-environment interactions in schizophrenia Pletnikov, M.
 2009
 19 Supplement 1 p. S200-
1 p.
 artikel
128 S.04.05 Effects of early exposure to ethanol and/or a cannabinoid receptor agonist on alcohol preference at adult age in mice Molet, J.
 2009
 19 Supplement 1 p. S181-S182
2 p.
 artikel
129 S.10.03 Modulating the mineralocorticoid receptor as add-on therapy in antidepressant treatment with SSRI: a randomised controlled trial Otte, C.
 2009
 19 Supplement 1 p. S193-S194
2 p.
 artikel
130 S.4.05 Novel neurotrophic factors for the treatment of neurodegenerative diseases Saarma, M.
 2009
 19 Supplement 1 p. S128-S129
2 p.
 artikel
131 S.25.03 Off-label use of antipsychotics: when is the benefit/risk ratio favourable? Anand, R.
 2009
 19 Supplement 1 p. S212-
1 p.
 artikel
132 S.20.05 Peripheral and brain BDNF as a marker of mood disorder Karege, F.
 2009
 19 Supplement 1 p. S206-
1 p.
 artikel
133 S.12.03 Phosphodiesterase inhibitors as a target for enhanced cognition Blokland, A.
 2009
 19 Supplement 1 p. S195-
1 p.
 artikel
134 S.28.02 Serotonergic regulation of the development of specific neurons Ugrumov, M.
 2009
 19 Supplement 1 p. S216-
1 p.
 artikel
135 S.04.08 Serotonin-1A receptor binding potential in dorsal raphe nuclei predicts orbitofrontal reactivity in healthy subjects Hahn, A.
 2009
 19 Supplement 1 p. S182-S183
2 p.
 artikel
136 S.24.02 The cell biology of Abeta generation Multhaup, G.
 2009
 19 Supplement 1 p. S211-
1 p.
 artikel
137 S.12.02 The glycine transporter 1 and its involvement in memory Singer, P.
 2009
 19 Supplement 1 p. S194-S195
2 p.
 artikel
138 The effects of synthetic and endogenous imidazoline binding site ligands on neuronal activity in discrete brain regions of naive and restraint-stressed rats Smith, Karen L.
 2009
 19 Supplement 1 p. 371-380
10 p.
 artikel
139 Tic hydantoin sigma-1 agonist: Pharmacological characterization on cocaine-induced stimulant and appetitive effects Toussaint, Marion
 2009
 19 Supplement 1 p. 504-515
12 p.
 artikel
                             139 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland